Investors

OvaScience is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility.

OVAS (Common Stock)
Price & Exchange
$43.47
NASDAQ
Change (%)
 Stock is Down 4.82 (9.98%)
Volume
1,964,508
03/27/15      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Webcast ImageWebcast
OvaScience AUGMENT KOL Call (Replay)
03/27/15 at 10:00 a.m. ET
OvaScience AUGMENT KOL Call
Friday, March 27, 2015 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Recent News

More »
DateTitle 
03/26/15OvaScience AUGMENT Fertility Treatment Shows Improved Pregnancy Rates in Women with Prior Failed IVF Cycles
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 26, 2015-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that presentations by fertility specialists offering the Company’s AUGMENTSM fertility treatment reported encouraging pregnancy rates in women who previously failed multiple cycles of in vitro fertilization (IVF). Clinical reports from two in... 
Printer Friendly Version
03/25/15OvaScience to Host Conference Call and Webcast Presentation with IVF Specialists to Review Early AUGMENT Fertility Treatment Patient Experience
Overview of AUGMENT Presentation at Society for Reproductive Investigation Meeting and Select Patient Case Studies CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 25, 2015-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today a conference call focused on the AUGMENTSM treatment on Friday, March 27, 2015 at 10:00 am ET. The presentation will follow... 
Printer Friendly Version
03/17/15AUGMENT Fertility Treatment to be Highlighted at Society for Reproductive Investigation (SRI) Annual Meeting
First Clinical Experience Presentations to Include Initial Pregnancy Data CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 17, 2015-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that in vitro fertilization (IVF) specialists from select international clinics will present initial clinical experience with OvaScience’s AUGMENTSM fertility ... 
Printer Friendly Version
03/17/15OvaScience CEO Michelle Dipp Elected as Young Global Leader by World Economic Forum
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 17, 2015-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, is pleased to announce that Michelle Dipp, M.D., Ph.D., was elected to join the World Economic Forum’s Young Global Leaders (YGL). Dr. Dipp’s commitment to the global community – particularly the fertility community – as well as her leadership and the contri... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Powered by Thomson Reuters
Data Provided by Thomson Reuters
Minimum 20 minutes delayed